In this section of the course, you have come across two drugs which inhibit dihydrofolate reductase. One of thes drugs is used as an antibacterial drug and the other is used in treatment of cancer. Why is it that each of these drugs can only be used for one purpose (and not the other) in clinical medicine.

In this section of the course, you have come across two drugs which inhibit dihydrofolate reductase. One of thes drugs is used as an antibacterial drug and the other is used in treatment of cancer. Why is it that each of these drugs can only be used for one purpose (and not the other) in clinical medicine.

Chemistry & Chemical Reactivity

10th Edition

ISBN:9781337399074

Author:John C. Kotz, Paul M. Treichel, John Townsend, David Treichel

Publisher:John C. Kotz, Paul M. Treichel, John Townsend, David Treichel

Chapter14: Chemical Kinetics: The Rates Of Chemical Reactions

Section14.7: Reaction Mechanisms

Problem 1.1ACP

See similar textbooks

Similar questions

Oligomycin is an antibiotic that allows electron transport to continue, but stops phosphorylation in bothbacteria and humans. Would you use it as an antibacterial drug for people? Explain.
Neostigmine is an inhibitor of acetylcholinesterase. The enzyme attempts to catalyse the same reaction on neostigmine as it does with acetylcholine. However, a stable intermediate is formed which prevents completion of the process and which results in a molecule being covalently linked to the active site. Identify (draw) the stable intermediate and explain why it is stable.
The enzyme d-amino acid oxidase has avery high turnover number because the d-amino acids are potentially toxic. The KM for the enzyme is in the range of 1 to2 mM for the aromatic amino acids and in the range of 15 to20 mM for such amino acids as serine, alanine, and the acidicamino acids. Which of these amino acids are the preferred substrates for the enzyme?
Provide a mechanism that would support this reaction. It is similar to a step in the Citric Acid Cycle. Please answer very soon will give rating surely
first explain what endergonic and exergonic reactions are in your words,now relate both the reactions with biosynthetic and biodegraditve pathways example.
Human xanthine oxidase catalyzes the oxidation of hypoxanthine to xanthine and can further catalyze the oxidation of xanthine to uric acid. For the treatment of hyperuricemia and gout, several medications are used to inhibit the activity of xanthine oxidase and reduce the production of uric acid. You are a biochemist and just discovered a chemical that can inhibit the activity of the human xanthine oxidase. When analyzing its mode of inhibition, you found that the enzyme inhibitor complex requires 450 J/mol to dissociate and that it displays kinetics somehow similar to noncompetitive inhibition. You sent your inhibitor to the ministry of health for approval as a medication for gout. Based on the data provided, are they going to authorize it as a medication or not? Explain?
Express the initial velocity of α-amylase in terms of substrate disappearance and product (as glucose) formation.
please please help me to answer it >>> i have an exam Human xanthine oxidase catalyzes the oxidation of hypoxanthine to xanthine and can furthercatalyze the oxidation of xanthine to uric acid. For the treatment of hyperuricemia and gout,several medications are used to inhibit the activity of xanthine oxidase and reduce theproduction of uric acid. You are a biochemist and just discovered a chemical that can inhibitthe activity of the human xanthine oxidase. When analyzing its mode of inhibition, you foundthat the enzyme inhibitor complex requires 450 J.mol-1 to dissociate and that it displayskinetics somehow similar to noncompetitive inhibition. You sent your inhibitor to the ministryof health for approval as a medication for gout. Based on the data provided, are they going toauthorize it as a medication or not? Explain?
please explain why this happends, im having trouble in this section. Part A Chymotrypsin, an enzyme that hydrolyzes peptide bonds in proteins, functions in the small intestine at an optimum pH of 7.7 to 8.0. How is the rate of the chymotrypsin-catalyzed reaction affected by each of the following conditions?
Don't give handwritten answers please Please provi the intermediate obtained at each step of the synthesis.
Imidazoleglycerol‑phosphate dehydratase is an enzyme in the histine biosynthesis pathway. It catalyzes the E1 dehydration of D‑erthyro‑imidazole‑glycerol phosphate to imidazole acetol‑phosphate. This is a rare example of a biological E1 reaction, as most biological elimination reactions occur through E1cB instead. In this reaction, D‑erthyro‑imidazole‑glycerol phosphate is first protonated to form a good leaving group. Then, the leaving group is ejected to form the resonance‑stabilized carbocation shown. Draw curved arrows forming the most stable resonance structure to explain why this reaction goes through an E1 mechanism. Draw curved arrows to form the most stable resonance structure.
Why is the reaction that is catalyzed by E3 in the oxidative decarboxylation of pyruvate by the pyruvate dehydrogenase complex not involved in the forming of the product (acetyl CoA) but still is important to the process of the complex? Explain why it is important.